D57.45 Sickle-cell thalassemia beta plus with crisis

Name of the Condition

• Sickle-cell thalassemia beta plus with crisis

Summary

Sickle-cell thalassemia beta plus with crisis is a genetic blood disorder resulting from the co-inheritance of sickle cell disease and beta plus thalassemia mutations. It causes red blood cells to become abnormal in shape and function, leading to complications such as anemia, pain, and organ damage. The presence of crisis indicates an acute phase with vaso-occlusive episodes.

Causes

Sickle-cell thalassemia beta plus arises from co-inheritance of mutations in the hemoglobin gene (HBB). One parent contributes a sickle cell mutation, while the other contributes a beta plus thalassemia mutation. This combination alters hemoglobin structure, resulting in sickle-shaped red blood cells and reduced hemoglobin production.

Risk Factors

• Family history of sickle-cell disease or thalassemia
• Ethnic backgrounds with higher prevalence of these conditions (e.g., Mediterranean, Middle Eastern, Indian, or African descent)
• Inheriting one sickle cell gene and one beta plus thalassemia gene increases the risk of passing the disorder to offspring

Symptoms

• Fatigue and weakness due to anemia
• Jaundice (yellowing of the skin or eyes)
• Swelling in hands and feet (dactylitis)
• Frequent infections
• Delayed growth or puberty in children
• Episodes of severe pain (vaso-occlusive crises)

Diagnosis

Diagnosis involves blood tests to identify sickle-shaped red blood cells and hemoglobin electrophoresis to confirm the specific beta plus thalassemia mutation. Genetic testing may be used to verify the co-inheritance of both mutations.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include pain management during crises, blood transfusions, hydroxyurea to reduce crisis frequency, and folic acid supplementation. In severe cases, bone marrow transplantation may be considered.

Prognosis and Follow-Up

Prognosis varies based on the severity of the condition and response to treatment. Regular follow-up with a hematologist is essential to monitor for complications such as organ damage or increased infection risk. Adherence to treatment plans can improve quality of life and reduce acute episodes.

Complications

• Acute chest syndrome
• Stroke
• Organ damage (e.g., spleen, kidneys, liver)
• Increased risk of infections
• Pulmonary hypertension

Lifestyle & Prevention

• Stay hydrated to reduce crisis risk
• Avoid extreme temperatures
• Practice good hand hygiene to prevent infections
• Follow a balanced diet rich in iron and folic acid
• Avoid smoking and excessive alcohol consumption

When to Seek Professional Help

Seek immediate medical attention for severe pain, difficulty breathing, signs of infection (e.g., fever), or sudden weakness. Regular check-ups are necessary to monitor overall health and adjust treatment as needed.

Tips for Medical Coders

Document the presence of vaso-occlusive crisis and specify the beta plus thalassemia component to support accurate coding. Ensure clinical documentation aligns with the diagnosis and includes details of acute episodes or complications to justify the code assignment.